Latest news
Lilly confident in slow and steady Foundayo launch, as ex-US sales shine - BioSpaceBioSpace · Wed, 05 Aug 2026 18:20:42 GMTLilly’s $23B Q2 soars over expectations but Foundayo lags Novo’s rival oral GLP-1 - BioSpaceBioSpace · Wed, 05 Aug 2026 13:39:37 GMTLilly and Resilience invest $750M in diabetes and obesity drug device supply - BioSpaceBioSpace · Fri, 31 Jul 2026 07:00:00 GMT